“Digoxin toxicity”的搜索结果，显示 401-410 项，共有 11951 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT), and recommended Phase 2 dose ...

5. 放射科- 临床试验- 妙佑医疗国际

   The main questions the study aims to answer in Phase/Part 1 of the trial are: * Is \[Ac225\]RTX-2358 tolerable or does it cause toxicities (medical problems) in ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

7. 关于 - 妙佑医疗国际

   概述. Radiopharmaceuticals are medicines that contain a small amount of a radioactive substance. Healthcare professionals use them to diagnose and treat ...

8. 血液科- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to collect Biospecimens from patients who developed chemotherapy related cardiac toxicity (CRCT) and patients who are ...

9. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

10. 血液科- 临床试验- 妙佑医疗国际

    Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and ...